Clinical Trials Directory

Trials / Unknown

UnknownNCT01429233

Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients

Real Life Experience of the Use of Isomers as ALENCAL(Levoamlodipine) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Closter Pharma · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a Phase 4, observational, open study in patients whom their doctor for clinical practice prescribes levamlodipine. No medication was provided by the sponsor. The planned observation time is 8 weeks. The 8 weeks of observation involves an evaluation of baseline followed by information gathered from the assessment visits at week 4 and week 8, or clinical practice.

Conditions

Timeline

Start date
2011-08-01
Primary completion
2011-12-01
Completion
2012-03-01
First posted
2011-09-07
Last updated
2011-09-07

Locations

1 site across 1 country: Colombia

Source: ClinicalTrials.gov record NCT01429233. Inclusion in this directory is not an endorsement.

Real Life Experience of the Use of Isomers as ALENCAL (Levamlodipine) for Evaluation of Efficacy, Safety and Tolerabilit (NCT01429233) · Clinical Trials Directory